GSK plcGSK
Price (close)
$49.65
Market cap
$99.4B
P/E
—
Revenue (FY)
$32.7B
Net income
$5.7B
Dividend yield
3.66%
1-year total return
30.1%
Net margin
17.5%
Revenue growth
4.1%
Debt / equity
0.90x
What GSK plc does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $24.4B | $24.7B | $29.3B | $30.3B | $31.4B | $32.7B |
| Net income | $5.7B | $4.4B | $15.0B | $4.9B | $2.6B | $5.7B |
| Free cash flow | $7.5B | $7.0B | $6.3B | $5.5B | $5.2B | $6.4B |
More on GSK.
- GSK plc summary
- GSK plc financial statements
- GSK plc key metrics
- GSK plc health scores and style box
- GSK plc earnings
- GSK plc dividends
- GSK plc valuation
- GSK plc ownership and insiders
- GSK plc peers
Figures from GSK plc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.